The quest for an animal model of diabetic nephropathy and the role of taurine deficiency.

作者: Xiaobin Han , Takashi Ito , Junichi Azuma , Stephen W. Schaffer , Russell W. Chesney

DOI: 10.1007/978-3-319-15126-7_19

关键词:

摘要: Diabetic nephropathy is the leading cause of end stage renal disease in man. Despite efforts, an ideal animal model that can reproduce characteristics human diabetic has not been developed. To this end, we hypothesize taurine deficiency one critical risk factors for development patients with diabetes mellitus. This hypothesis be tested vivo TauT knockout (TauT −/−) C57BL/6 background mice. We asked whether would enhance streptozotocin-treated mouse. provide evidence alteration gene a substantial effect on susceptibility to kidney −/− mouse diabetes. These animals specifically developed characteristic histological changes included glomerulosclerosis, nodular lesions, arteriosclerosis, arteriolar dilation, and tubulointerstitial fibrosis. Immunohistochemical staining molecular markers such as smooth muscle actin, CD34, Ki67, collagen IV confirmed these observations were abnormal. The results demonstrated deletion predisposes mice develop end-stage disease, which closely replicates pathological features and, thus, serve therapeutic strategies.

参考文章(20)
Edward H. Leiter, Andrew Schile, Genetic and Pharmacologic Models for Type 1 Diabetes Current Protocols in Mouse Biology. ,vol. 3, pp. 9- 19 ,(2013) , 10.1002/9780470942390.MO120154
M. Kakoki, K. A. Sullivan, C. Backus, J. M. Hayes, S. S. Oh, K. Hua, A. M. H. Gasim, H. Tomita, R. Grant, S. B. Nossov, H.-S. Kim, J. C. Jennette, E. L. Feldman, O. Smithies, Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 10190- 10195 ,(2010) , 10.1073/PNAS.1005144107
Svend H�ime Hansen, The role of taurine in diabetes and the development of diabetic complications Diabetes-metabolism Research and Reviews. ,vol. 17, pp. 330- 346 ,(2001) , 10.1002/DMRR.229
Susan B. Gurley, Carrie L. Mach, Johannes Stegbauer, Jihong Yang, Kamie P. Snow, Ann Hu, Timothy W. Meyer, Thomas M. Coffman, Influence of genetic background on albuminuria and kidney injury in Ins2+/C96Y (Akita) mice American Journal of Physiology-renal Physiology. ,vol. 298, ,(2010) , 10.1152/AJPRENAL.90515.2008
Takashi Ito, Yasushi Kimura, Yoriko Uozumi, Mika Takai, Satoko Muraoka, Takahisa Matsuda, Kei Ueki, Minoru Yoshiyama, Masahito Ikawa, Masaru Okabe, Stephen W. Schaffer, Yasushi Fujio, Junichi Azuma, Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy Journal of Molecular and Cellular Cardiology. ,vol. 44, pp. 927- 937 ,(2008) , 10.1016/J.YJMCC.2008.03.001
Kelly L. Hudkins, Warangkana Pichaiwong, Tomasz Wietecha, Jolanta Kowalewska, Miriam C. Banas, Min W. Spencer, Anja Mühlfeld, Mariko Koelling, Jeffrey W. Pippin, Stuart J. Shankland, Bardia Askari, Mary E. Rabaglia, Mark P. Keller, Alan D. Attie, Charles E. Alpers, BTBR Ob/Ob Mutant Mice Model Progressive Diabetic Nephropathy Journal of The American Society of Nephrology. ,vol. 21, pp. 1533- 1542 ,(2010) , 10.1681/ASN.2009121290
Detlef Schlöndorff, Choosing the right mouse model for diabetic nephropathy. Kidney International. ,vol. 77, pp. 749- 750 ,(2010) , 10.1038/KI.2009.545
Stephanie Franzén, Malou Friederich-Persson, Angelica Fasching, Peter Hansell, Masaomi Nangaku, Fredrik Palm, Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes. American Journal of Physiology-renal Physiology. ,vol. 306, ,(2014) , 10.1152/AJPRENAL.00595.2013
Xiaobin Han, Russell W. Chesney, The role of taurine in renal disorders Amino Acids. ,vol. 43, pp. 2249- 2263 ,(2012) , 10.1007/S00726-012-1314-Y